The North America Anti-Infective Agents Market is increasingly connected to regional surveillance systems that track resistance patterns and antimicrobial utilization. Laboratory data can help healthcare providers understand local pathogen susceptibility and refine treatment protocols. Integration of microbiology, prescribing, and epidemiological information can improve the speed of treatment...

In late 2026, the industry is pivoting toward "Distributed Surveillance." This year, a radical new class of "Smart Diagnostic Hubs" is being installed in community clinics and nursing homes, far away from the major city hospitals. This innovation is a primary driver for the market, as it captures "Community-Acquired Resistance" data that was previously missed by centralized surveillance...